Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

alkiviadis.1961 shared this article with you from Inoreader Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease Via The New England Journal of Medicine: Search Results in Endocrinology Patients with diabetes mellitus are at high risk for both heart failure and ischemic events. Sodium–glucose cotransporter 2 (SGLT2) inhibitors have been shown to be effective for the treatment of type 2 diabetes mellitus and to lower the risk of hospitalization for heart failure among patients with… View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.